Assenagon Asset Management S.A. Durect Corp Transaction History

Assenagon Asset Management S.A.

  • $54.1 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 17, 2020
SELL
$0.97 - $2.85 $96,324 - $283,016
-99,304 Closed
0 $0
Q4 2019

Jan 17, 2020
SELL
$1.69 - $3.8 $567,370 - $1.28 Million
-335,722 Reduced 77.17%
99,304 $377,000
Q3 2019

Oct 16, 2019
BUY
$0.61 - $2.21 $265,365 - $961,407
435,026 New
435,026 $800,000

Others Institutions Holding DRRX

# of Institutions
3
Shares Held
593K
Call Options Held
0
Put Options Held
0
View Full List

About DURECT CORP

DRRX Quotes by TradingView
  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $175M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email